In the present study, using a murine model of LPS-induced acute peritonitis, we demonstrated administration of IL-10 inhibits inflammatory response via reduction of proinflammatory cytokines, including IL-1β, IL-18, and TNF-α in PLF and serum. This evidence concerns the gene IL1B and peritonitis.